Close
Help





JOURNAL

Clinical Medicine Reviews in Women's Health

Depot Medroxyprogesterone Acetate: Safety and Efficacy Update

Submit a Paper


Clinical Medicine Reviews in Women's Health 2010:2

Review

Published on 28 Nov 2010

DOI: 10.4137/CMRWH.S1641


Further metadata provided in PDF

Download Article PDF


Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Women's Health

Abstract

Depot medroxyprogesterone acetate (DMPA) is a long-acting, reversible progestin-only contraceptive method that is administered either intramuscularly or subcutaneously every 12 weeks. Because of its high efficacy, ease of use, privacy, and non-contraceptive benefits, adolescent and adult women are increasingly utilizing DMPA as their contraceptive method of choice. Though there are very few contraindications for use, the method has several side effects that should be discussed with patients before initiation to enhance satisfaction with and maintenance of the method.



Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)





Quick Links


New article and journal news notification services